亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

上海西睿化工有限公司  

公司主要生產(chǎn)并銷售核苷酸,糖類衍生物和氨基酸衍生物。

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:歐陽百川
  • 電話:021-61553265
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 西睿化工大量供β-胸苷50-89-5;157049-39-3
西睿化工大量供β-胸苷50-89-5;157049-39-3
單價 面議對比
詢價 暫無
發(fā)貨 上海付款后3天內(nèi)
品牌 西睿化工
過期 長期有效
更新 2015-10-28 16:32
 
詳細信息
 中文名稱:
β-胸腺嘧啶核苷
中文別名:
胸苷;β-胸苷;胸腺嘧啶核苷
英文名稱:
Thymidine
英文別名:
(1-[2-Deoxy-beta-D-ribofuranosyl]-5-methyluracil); 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-D-erythro-pentofuranosyl)-5-methyl-; 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-D-ribofuranosyl)-5-methyl-; 2'-Deoxythymidine; 5-Methyldeoxyuridine; beta-D-Ribofuranoside,thymine-1,2-deoxy-; Deoxythymidine; Dexoythymidine; dT; DThyd; Thymine-2-desoxyriboside; Thyminedeoxyriboside; Uridine,2'-deoxy-5-methyl-; Beta-Thymidine; β-Thymidine; -Thymidine; 1-[(3xi)-2-deoxy-beta-D-glycero-pentofuranosyl]-5-methylpyrimidine-2,4(1H,3H)-dione; 1-(2-deoxy-beta-L-threo-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione; 1-(2-deoxy-alpha-D-threo-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione
CAS號:
50-89-5
EINECS號:
200-070-4
分子式:
C10H14N2O5
分子量:
242.2286 
©2025 上海西睿化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:3276  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |